Introduction of new micronized formation for severe recalcitrant nodular acne treatment is a major factor that is expected to boost the growth of the global isotretinoin drugs market at a CAGR of 4.68% during the forecast period of 2023 to 2032 :

Market Research Future (MRFR) has published a cooked research report on the “Global Isotretinoin Drugs Market” that contains the information from 2023 to 2032.


Market Highlights


The global isotretinoin drugs market is expected to register a CAGR of 4.68% during the forecast period and is expected to hit USD 1.81 Billion by 2032.


The global isotretinoin drugs market is expected to witness a steady growth rate during the study period. This is due to the rising prevalence of acne and skin cancer. The market growth is further supplemented by the rising adoption of unhealthy lifestyles globally.


The growth of the global isotretinoin drugs market is expected to be driven by the increasing prevalence of acne among teens & young adults and increasing incidence of neuroblastoma. However, the concerns pertaining to drug side effects are acting as a restraining factor for the market growth. On the other hand, collaborations of major players with regional players increase the lucrativeness of this market. Opportunities propelling the growth of the isotretinoin drugs reagents market include the introduction of new micronized formation for severe recalcitrant nodular acne treatment.


Key Players:


MRFR recognizes the following companies as the key players in the global isotretinoin drugs market— Douglas Pharmaceuticals Ltd (New Zealand), Teva Pharmaceuticals Industries, Inc. (Israel), Dr. Reddy’s Laboratories (India), F. Hoffmann La Roche (Europe)., Mylan (US), Akorn (US), Catalent Pharma Solutions (US), Chongqing Huapont (China), Cipher Pharmaceuticals (US), GlaxoSmithKline (UK), and Sun Pharmaceuticals (India) among others.


Segment Analysis


The global isotretinoin drugs market is mainly segmented into form, indication, and distribution channel. On the basis of form, the isotretinoin drugs market has been sub-segmented into capsule and injection. Based on indication, global the isotretinoin drugs market has been segmented into severe acne, squamous cell carcinoma, cutaneous t-cell lymphoma, neuroblastoma, harlequin ichthyosis, xeroderma pigmentosum and fibrodysplasia ossificans progressiva. By distribution channel,  the market has is categorized into hospital pharmacies, retail pharmacies and online pharmacies.


Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Isotretinoin Drugs Market Research Report


Regional Analysis


The global isotretinoin drugs market has been segmented on the basis of region into North America, Europe, Asia-Pacific, and the Rest of the World. The North American market is further divided into the US and Canada. The European isotretinoin drugs market has been segmented into Germany, France, the UK, Italy, Spain, Russia, Ukraine, and the rest of Europe. The isotretinoin drugs market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World isotretinoin drugs market includes the Middle East, Africa, and Latin America.


The North America accounted for the largest market share of 38.56% in 2020 and is anticipated to reach approximately USD 653.69 million by 2027 at an 5.06% CAGR during the forecast period. The region holds the largest market share in the isotretinoin drugs market due to developed healthcare infrastructure, favorable government regulations, rising prevalence of various skin problems, genetic disorders, and cancer, as well as increased R&D investment in the region.


The Europe held the the second largest market share in the global isotretinoin drugs market. This growth can be mainly attributed to the rising cases of various genetic disorders and skin cancer, the rapidly developing healthcare sector, rising healthcare spending, and increasing awareness of disorders and diseases in the Western European region. Moreover, key players headquartered in the region are innovating and driving growth in the regional market.


Key Findings of the Study



  • The global isotretinoin drugs market is expected to reach USD 1.81 Billion by 2032 at a CAGR of 4.68% during the forecast period.

  • The North America region accounted for the largest share of 38.56% in the global isotretinoin drugs market in 2020.

  • Based on form, the injection segment is expected to register a CAGR of 6.04% during the forecast period.

  • By indication, the severe acne dominated the market with a share of 25% in 2020.

  • On the basis of distribution channel, the hospital pharmacies segment held the largest market share in 2020, while online pharmacies is expected to be the fastest growing segment during the study period.

  • Some of the key players operating in the isotretinoin drugs market are Douglas Pharmaceuticals Ltd (New Zealand), Teva Pharmaceuticals Industries, Inc. (Israel), Dr. Reddy’s Laboratories (India), F. Hoffmann La Roche (Europe)., Mylan (US), Akorn (US), Catalent Pharma Solutions (US), Chongqing Huapont (China), Cipher Pharmaceuticals (US), GlaxoSmithKline (UK), and Sun Pharmaceuticals (India) among others.